Drug Approval | March 25, 2022
USFDA approves Janssen’s injectable regimen for HIV
Cabenuva was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen's decades-long commitment to combatting HIV
Cabenuva was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen's decades-long commitment to combatting HIV
A new course at the Azrieli Faculty of Medicine will focus on tissue regeneration and 3D printing for therapeutic needs
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
Organizations to combine expertise to further develop AI/ML-powered drug design platform, delivering precise, effective, and life-changing medicines at scale
Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers
She joined Trivitron Healthcare in 1999 and has held several positions in the organisation
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
In contrast to the digital health solutions in the market, TEngage is cloud-based, fully customizable and allows hospitals to implement modules with just the required features, keeping the deployment and operational cost in check
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
CEPI will expand its partnership with icddr,b in Bangladesh, providing near to the additional US $ 1 million in funding to advance understanding of the Nipah virus
Subscribe To Our Newsletter & Stay Updated
